Ignite Creation Date:
2024-05-06 @ 8:24 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06361628
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-17
First Post:
2024-03-20
Brief Title:
Implementation and Evaluation of Tailored Interventions to Increase MMR andor HPV Vaccine
Sponsor:
University Medical Center Groningen
Organization:
University Medical Center Groningen
Study Overview
Official Title:
Implementation and Evaluation of Tailored Interventions to Increase MMR andor HPV Vaccine Uptake in Underserved Communities in Greece The Netherlands Poland and Slovakia
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
RIVER-EU
Brief Summary:
The goal of the study is to monitor and evaluate the implementation of interventions that aim to increase HPV MMR vaccines among underserved communities across four European countries Greece Netherlands Poland and Slovakia The interventions will target identified health systems barriers in an earlier phase of the project The interventions that will be implemented employ trusted community members as health promotors whom will provide educational sessions on HPV and MMR vaccination to the target groups In addition the cost-effectiveness of vaccine uptake strategies for the target groups is being evaluated
The main research question is to what extent is the multicomponent tailored intervention effective to increase MMRHPV intention and vaccine uptake in the target population in Greece Netherlands Poland and Slovakia
The main research question is to what extent is the multicomponent tailored intervention effective to increase MMRHPV intention and vaccine uptake in the target population in Greece Netherlands Poland and Slovakia
Detailed Description:
The general objective of the study is to improve access to vaccination by addressing relevant system level barriers to increase HPV and MMR where applicable vaccine intention and uptake among the target groups The investigators expect that the intervention will address health system barriers to improve increase in access to information on vaccination and vaccination services
A prospective multicomponent intervention study will be performed between 1st of April 2024 and 31st of July 2025 that will be evaluated using a pre and post design as well as a participatory approach during the implementation As part of the multicomponent intervention a preparatory phase is taken place before this period of time The multicomponent intervention consists of training of health promotors and healthcare professionals and of educational sessions to community members and navigation The educational sessions will be offered at suitable and accessible locations for the target population
The five communities targeted in are the following
1 The migrant community in Greece HPV and MMR
2 Turkish and Moroccan women in the Netherlands HPV
3 The Ukrainian community in Poland HPV and MMR
4 The Roma community in Slovakia HPV
A prospective multicomponent intervention study will be performed between 1st of April 2024 and 31st of July 2025 that will be evaluated using a pre and post design as well as a participatory approach during the implementation As part of the multicomponent intervention a preparatory phase is taken place before this period of time The multicomponent intervention consists of training of health promotors and healthcare professionals and of educational sessions to community members and navigation The educational sessions will be offered at suitable and accessible locations for the target population
The five communities targeted in are the following
1 The migrant community in Greece HPV and MMR
2 Turkish and Moroccan women in the Netherlands HPV
3 The Ukrainian community in Poland HPV and MMR
4 The Roma community in Slovakia HPV
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None